U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07230730) titled 'A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia' on Sept. 22.
Brief Summary: The study is being conducted to evaluate the efficacy, and safety of SHR-1918 in reducing serum low-density lipoprotein cholesterol (LDL-C) and total triglycerides (TG) in patients with hyperlipidemia compared with placebo, and also includes To evaluate the effectiveness of SHR-1918 in reducing other lipid indicators in patients with mixed hyperlipidemia and to assess the safety of SHR-1918 in patients with mixed hyperlipidemia.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Hyperlipidemia
Int...